top of page

Panel:

year

Video Link:

CYBERIA_1.png
NeuroRX, Inc.
More than 500 people with bipolar disease die each day from suicidal crisis across the OECD countries. NeuroRx has demonstrated human proof of concept for a first-in-class, rapid-onset, sustained therapy therapy for this condition, which currently has no approved treatment.

CYBERIA_1.png
NeuroRX, Inc.

2015

bottom of page